The effect of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head

The effect of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head - The effect of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017582

Enrollment

100

Registered

2015-05-15

Start date

2015-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nontraumatic osteonecrosis of the femoral head

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Nontraumatic osteonecrosis of the femoral head patients who were diagnosed with steroid-induced osteoporosis and received teriparatide or alendronate

Exclusion criteria

Exclusion criteria: We excluded 1) Patients who had been followed for less than 6 months 2) The administration periods were not identified 3) Stage 3B or 4 in the Japansese Investigation Committee staging system 4) Type A or B in the Japansese Investigation Committee classification system

Design outcomes

Primary

Measure	Time frame
The effects of anti-collapse efficacy of teriparatide compared with alendronate	—

Countries

Japan

Contacts

Public ContactRyuta Arai

Hokkaido University Graduate School of Medicine Department of Orthopaedic surgery

ryutaaraisti@yahoo.co.jp011-716-1161

Outcome results